MAIA Biotechnology, Inc. (MAIA)
US Market

MAIA Biotechnology, Inc. (MAIA) Stock Price & Analysis


MAIA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.12 - $9.64
Previous Close$2.3
Average Volume (3M)56.87K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$7.59M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-1.4
Aug 21, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.64
Shares Outstanding13,625,925
10 Day Avg. Volume28,916
30 Day Avg. Volume56,865
Standard Deviation0.21
Financial Highlights & Ratios
Price to Book (P/B)3.64
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Price Target Upside508.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was MAIA Biotechnology, Inc.’s price range in the past 12 months?
MAIA Biotechnology, Inc. lowest stock price was $2.12 and its highest was $9.64 in the past 12 months.
    What is MAIA Biotechnology, Inc.’s market cap?
    Currently, no data Available
    When is MAIA Biotechnology, Inc.’s upcoming earnings report date?
    MAIA Biotechnology, Inc.’s upcoming earnings report date is Aug 21, 2023 which is in 83 days.
      How were MAIA Biotechnology, Inc.’s earnings last quarter?
      MAIA Biotechnology, Inc. released its earnings results on May 08, 2023. The company reported -$0.38 earnings per share for the quarter, beating the consensus estimate of -$0.4 by $0.02.
        Is MAIA Biotechnology, Inc. overvalued?
        According to Wall Street analysts MAIA Biotechnology, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does MAIA Biotechnology, Inc. pay dividends?
          MAIA Biotechnology, Inc. does not currently pay dividends.
          What is MAIA Biotechnology, Inc.’s EPS estimate?
          MAIA Biotechnology, Inc.’s EPS estimate is -$0.38.
            How many shares outstanding does MAIA Biotechnology, Inc. have?
            MAIA Biotechnology, Inc. has 13,625,925 shares outstanding.
              What happened to MAIA Biotechnology, Inc.’s price movement after its last earnings report?
              MAIA Biotechnology, Inc. reported an EPS of -$0.38 in its last earnings report, beating expectations of -$0.4. Following the earnings report the stock price went down -6.69%.
                Which hedge fund is a major shareholder of MAIA Biotechnology, Inc.?
                Currently, no hedge funds are holding shares in MAIA


                MAIA Biotechnology, Inc. Stock Smart Score

                Not Ranked
                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                MAIA Biotechnology, Inc.

                MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of telomerase-positive cancer cells.


                Top 5 ETFs holding MAIA

                Currently, no data available
                Please return soon. This page is being updated.
                Up to five ETFs with an Outperform Smart Score that hold MAIA. The ETFs are listed according to market value of MAIA within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Jounce Therapeutics
                TScan Therapeutics
                Protara Therapeutics
                Unity Biotechnology

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis